1155846-86-8
C13H6ClF3N2O2
314.65
1.54±0.1
98% min
Anti-HIV
Doravirine
10/7/2031 (Doravirine)
HIV-1 reverse transcriptase
N
2020
ISO 9001;ISO 14001;ISO 45001
Generic Giant Supplied in 2020 and 2021
Availability: | |
---|---|
DESCRIPTION
With its powerful efficacy and favorable tolerability, Doravirine empowers patients with a simplified and effective treatment option. As a non-nucleoside reverse transcriptase inhibitor (NNRTI), Doravirine offers exceptional virologic suppression and resistance resistance against common HIV strains. By incorporating Doravirine into your pharmaceutical portfolio, you can enhance patient care, expand treatment options, and make a significant impact on combating the global HIV epidemic. Stay at the forefront of innovation with Doravirine to transform the lives of those living with HIV.
ROS
To align with green chemistry, we have implemented the flow chemistry.
Downloads